Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients
Launched by MASK-AIR SAS · Dec 9, 2022
Trial Information
Current as of January 16, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether a special cat food can help reduce allergy symptoms in people who are allergic to cats. Cat allergies are quite common and can cause sneezing, coughing, and even asthma. The food being tested contains a unique ingredient that aims to neutralize a key allergen found in cats. The goal is to see if changing a cat’s diet to this special food can lead to fewer allergic reactions in their owners.
To participate in this study, you need to have allergic rhinitis (which means you experience allergy symptoms like sneezing and congestion), and you should have at least one or two cats at home that typically eat dry kibble. You must agree to feed your cats only the test food during the study. Participants also need to use a smartphone app to help track their symptoms. If you meet these criteria and are interested, this study could provide a new way to manage cat allergies while keeping your furry friends close!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Uncontrolled allergic rhinitis (with or without treatment)
- • Persistent allergic rhinitis with worsening of symptoms upon exposure to cats
- • Presence of one or two cats in the household, whose diet consists mainly of dry kibble
- • Agreement of the patient to change the food of the cat(s) and to feed it exclusively with the test kibbles during the study.
- • Diagnosis of cat allergy defined by a positive prick test to standardized cat allergen or cat-specific IgE.
- • Absence of allergy to pollens emitted in the region during the 4 months following the inclusion date, confirmed by a negative skin test.
- • Person owning an android and/or IOS smartphone and having the possibility to connect to the internet (via phone subscription or WIFI connection),
- • Person who agrees to install the MASK-air application (medical device) on his personal smartphone,
- • Person having read and understood the information note and having signed their participation agreement before any specific procedure of the study.
- Exclusion Criteria:
- • Person planning to be away from the cat(s) for more than one week/month in the 4 months following the inclusion visit
- • Patient who has had a new cat in the home for less than one month
- • Patient in regular contact with other animals to which they are allergic
- • Patient with uncontrolled asthma
- • Patient receiving immunotherapy for cat allergies
- • Patient participating or having participated in an allergic rhinitis study within the last 30 days or 5 half-lives of study medication
- • Person who has difficulty understanding or reading the information
- • Person declaring to be under guardianship, curatorship or safeguard of justice.
Trial Officials
Nan Pham-Thi, Dr
Principal Investigator
Allergologist
About Mask Air Sas
Mask-Air SAS is a pioneering clinical trial sponsor dedicated to advancing respiratory health through innovative medical solutions. Specializing in the development and evaluation of cutting-edge technologies for airway management, the company focuses on enhancing patient outcomes in respiratory care. With a commitment to rigorous scientific research and collaboration with healthcare professionals, Mask-Air SAS strives to bring effective and safe products to market, addressing the needs of patients and practitioners alike in the dynamic field of respiratory medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials